Patients with a substance abuse problem or addiction should be referred to a pain specialist. Theft or loss of controlled substances should be reported to the Drug Enforcement Administration. The activity should be documented and reported to law enforcement if drug diversion has occurred. 2.0 Purpose This rule implements the Vermont Prescription Monitoring System (VPMS) created by 18 V.S.A. chapter 84A, that requires the Department of Health to establish an electronic database and reporting system for monitoring dispensed prescriptions of controlled substances. The intent is to promote public health through enhanced opportunities to prevent, detect and treat misuse of Gabapentin, originally developed to treat epilepsy, has gained popularity as a medication for neuropathic pain and other conditions. However, its increasing use has raised concerns about potential misuse and addiction. As a result, various states have begun to classify gabapentin as a controlled substance. Understanding the legal status of gabapentin across different jurisdictions is crucial We would like to show you a description here but the site won’t allow us. § 4228. Unlawful manufacture, distribution, dispensing, or sale of a noncontrolled drug or substance § 4229. Maintenance of records § 4230. Cannabis § 4230a. Cannabis possession by a person 21 years of age or older § 4230b. Cannabis possession by a person 16 years of age or older and under 21 years of age; civil violation § 4230c. Gabapentin is a prescription medication approved by the FDA for the treatment of neuropathic pain (postherpetic neuralgia) and seizure disorders. Why is gabapentin controlled in some states? Gabapentin is structurally and pharmacologically related to pregabalin (Lyrica, Lyrica CR), which is a Schedule V drug and controlled federally in all states. Regulated Drug Rule 1.0 Authority This rule is established under the authority of 18 V.S.A. §§ 4201 and 4202 which authorizes the Vermont Board of Health to designate regulated drugs for the protection of public health and safety. Prescriptions in Vermont The Vermont Prescription Monitoring System (VPMS) is an electronic data system that collects information on the Schedule II-IV controlled substance prescriptions dispensed by Vermont-licensed pharmacies. VPMS proactively safeguards public health and safety while supporting the appropriate use of controlled substances. This rule designates drugs and other chemical substances that are illegal or judged to be potentially fatal or harmful for human consumption unless prescribed and dispensed by a professional licensed to prescribe or dispense them and used in accordance with the prescription. The rule restricts the possession of certain drugs above a specified quantity. The rule also establishes benchmark Pharmacy Statutes, Rules & Resources - Vermont Secretary of StatePharmacy Statutes, Rules & Resources The Board of Pharmacy, together with the Secretary of State’s Office of Professional Regulation (OPR), provide governance, oversight and enforcement for your profession. This page contains detailed information regarding applicable statutes and rules as well as additional resources. Pharmacy If gabapentin is, or becomes, a controlled substance in your state, it does not necessarily mean it will be more difficult to obtain. Rather, it is a safety measure to assure we are using medications appropriately. Talk with your doctor or pharmacist if you have questions or aren’t sure if gabapentin is working for you. Gabapentin is a controlled substance in states like Michigan and Kentucky, while others have mandated reporting rules. Learn about its risk for abuse here. We would like to show you a description here but the site won’t allow us. Gabapentin, initially developed for epilepsy, is now widely used for nerve pain and other off-label applications. Rising prescription rates have sparked discussions about whether it should be classified as a controlled substance due to concerns over misuse and dependency. (b) For the purposes of this section, a “controlled” drug or substance shall mean those drugs or substances listed under Schedules I through V in the federal Controlled Substances Act, 21 U.S.C. § 801 et seq. as amended. Gabapentin isn’t classified as a controlled substance under federal law in the United States. But it is classified as a controlled substance in some states. Title 18 : Health Chapter 084 : Possession and Control of Regulated Drugs Subchapter 001 : REGULATED DRUGS (Cite as: 18 V.S.A. § 4234) § 4234. Depressant, stimulant, and narcotic drugs (a) Possession. (1) (A) Except as provided by subdivision (B) of this subdivision (1), a person knowingly and unlawfully possessing a depressant, stimulant, or narcotic drug, other than heroin or cocaine Gabapentin and xylazine have emerged as drugs of concern. Gabapentin was involved in 13% of fatal opioid overdoses in 2022 (up from 2% in 2021), and xylazine was involved in 28% of fatal opioid overdoses (up from 13% in 2021). We would like to show you a description here but the site won’t allow us. These legislative efforts align with Vermont’s broader substance abuse prevention strategy. The state’s health officials continue pushing for stricter regulations on gabapentin sales and distribution while balancing patient access for legitimate medical needs.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |